BIO-CHEM(SH:603360) Xin Lang Cai Jing·2025-11-12 06:19Core Viewpoint - Baiao Chemical's stock has shown significant growth this year, with a year-to-date increase of 119.15%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the period from January to September 2025, Baiao Chemical achieved a revenue of 1.056 billion yuan, representing a year-on-year growth of 17.88% [2]. - The net profit attributable to shareholders for the same period was 125 million yuan, which reflects a substantial decrease of 50.83% compared to the previous year [2]. Stock Market Activity - As of November 12, Baiao Chemical's stock price was 33.89 yuan per share, with a trading volume of 327 million yuan and a turnover rate of 1.40% [1]. - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent occurrence on August 28 [1]. Shareholder Information - As of September 30, the number of shareholders for Baiao Chemical increased by 12.51% to 24,000, while the average number of circulating shares per person decreased by 11.12% to 29,483 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 4.0587 million shares, an increase of 1.6304 million shares from the previous period [3]. Business Overview - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1]. - The company's revenue composition includes 54.95% from industrial biocides and 44.36% from semiconductors, with minor contributions from other segments [1].